Cart
sales@molnova.com
Valategrast hydrochloride
CAS No. 828271-96-1
Valategrast hydrochloride( R-411 | RO-0272441 | RO-27-2441 | R411 | RO 0272441 | RO 27 2441 )
Catalog No. M16076 CAS No. 828271-96-1
Valategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 382 | Get Quote |
|
| 50MG | 1962 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameValategrast hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionValategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
-
DescriptionValategrast hydrochloride is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.Asthma Discontinued.
-
In VitroValategrast (hydrochloride) contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS).
-
In Vivo——
-
SynonymsR-411 | RO-0272441 | RO-27-2441 | R411 | RO 0272441 | RO 27 2441
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number828271-96-1
-
Formula Weight641.411
-
Molecular FormulaC30H33Cl4N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCCN(CC)CC)[C@H](CC1=CC=C(NC(C2=C(Cl)C=CC=C2Cl)=O)C=C1)NC(C3=C(C)C=CC=C3Cl)=O.[H]Cl
-
Chemical Name2-(diethylamino)ethyl (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-[(2,6-dichlorobenzoyl)amino]phenyl]propanoate hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sidduri A, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2479-82.
molnova catalog
related products
-
SF0166
SF0166 is a topically administered αvβ3 integrin antagonist, inhibits integrin-ligand interactions with IC50 of 0.6 nM to 13 nM for human αvβ3, αvβ6, and αvβ8.
-
Valategrast
Valategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
-
ALG1001
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis.
